Bleeding Risks with New Blood Thinners: What You Need to Know
Published: Aug 24, 2024
Blood thinners are lifesavers, preventing dangerous clots. But they come with a trade-off: an increased risk of bleeding. Understanding this risk is crucial for anyone taking these medications.
Contents
The Bleeding Basics
All blood thinners, including newer direct oral anticoagulants (DOACs), increase the risk of bleeding. This can range from minor bruising to more serious internal bleeding. The good news? DOACs generally have a lower risk of the most dangerous type of bleeding - in the brain - compared to older drugs like warfarin.
Who's at Higher Risk?
Certain factors can increase your bleeding risk on blood thinners. These include being over 75, having kidney problems, a history of stomach ulcers, or taking other medications that affect blood clotting (like aspirin). It's crucial to discuss all your medical conditions and medications with your doctor when considering blood thinners.

Signs to Watch For
While on blood thinners, it's important to be aware of bleeding signs. These can include unusual bruising, nosebleeds that won't stop, blood in urine or stools, or severe headaches. If you experience these symptoms, contact your healthcare provider immediately. Remember, prompt attention to bleeding can prevent more serious complications.
Minimizing the Risk
There are steps you can take to reduce your bleeding risk. Take your medication exactly as prescribed. Avoid activities with a high risk of injury. Be cautious with over-the-counter pain relievers, as some can increase bleeding risk. Regular check-ups with your doctor are important to monitor your health and adjust your treatment if needed.
Frequently Asked Questions
Generally yes, especially for brain bleeding.
Some are safe, but always check with your doctor.
Your doctor will guide you on when to stop the medication.
Yes, for some DOACs, but they're used only in emergencies.
Yes, like avoiding excessive alcohol and high-risk activities.
The Bottom Line
While bleeding risks exist with blood thinners, for many patients, the benefits of preventing clots outweigh these risks.
References
- Chai-Adisaksopha C, Hillis C, Isayama T, et al. Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost 2015; 13:2012.
- Desai J, Kolb JM, Weitz JI, Aisenberg J. Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies. Thromb Haemost 2013; 110:205.
- Southworth MR, Reichman ME, Unger EF. Dabigatran and postmarketing reports of bleeding. N Engl J Med 2013; 368:1272.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
15-min consultation. No hidden costs.
AI Doctor Visit Required
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?